×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AXNX – axonics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AXNX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
09:42 am
axnx
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors [Yahoo! Finance]
Low
Report
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors [Yahoo! Finance]
11/8
12:31 pm
axnx
Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
Low
Report
Axonics, Inc. (NASDAQ: AXNX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.
11/7
04:01 pm
axnx
Axonics Reports Third Quarter 2024 Financial Results
Low
Report
Axonics Reports Third Quarter 2024 Financial Results
9/27
12:17 pm
axnx
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device [Yahoo! Finance]
Low
Report
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device [Yahoo! Finance]
9/26
09:45 am
axnx
Axonics' sacral neuromodulation device cleared in Australia [Yahoo! Finance]
Neutral
Report
Axonics' sacral neuromodulation device cleared in Australia [Yahoo! Finance]
9/26
06:00 am
axnx
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Low
Report
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
9/25
09:42 am
axnx
Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic [Yahoo! Finance]
Low
Report
Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic [Yahoo! Finance]
9/19
07:44 am
axnx
Axonics did not infringe Medtronic's patents, jury rules [Yahoo! Finance]
Low
Report
Axonics did not infringe Medtronic's patents, jury rules [Yahoo! Finance]
Date
Time
Symbol
Headline
Impact
11/12
07:02 pm
axnx
Form 4 Axonics, Inc. For: Nov 07 Filed by: snyderman nancy lynn MD
Low
Report
Form 4 Axonics, Inc. For: Nov 07 Filed by: snyderman nancy lynn MD
11/7
04:10 pm
axnx
Form 10-Q Axonics, Inc. For: Sep 30
Low
Report
Form 10-Q Axonics, Inc. For: Sep 30
11/7
04:04 pm
axnx
Form 8-K Axonics, Inc. For: Nov 07
Low
Report
Form 8-K Axonics, Inc. For: Nov 07
10/3
07:25 pm
axnx
Form 4 Axonics, Inc. For: Oct 02 Filed by: Keese Kari Leigh
Neutral
Report
Form 4 Axonics, Inc. For: Oct 02 Filed by: Keese Kari Leigh
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/9
Axonics® Announces Preliminary Fourth Quarter and Full Year 2019 Revenue
20.8%
5/8 Q1/2019 3/31/2019 EPS -0.470 ZacksConsensus -0.400 ActVsEst (0.070) - Miss 19.5%
4/16 Form 8-K Axonics Modulation Techn For: Apr 16 13.3%
8/6 Form 4 Axonics Modulation Techn For: Aug 06 Filed by: COHEN RAYMOND W 10.3%
4/6 Axonics® Submits PMA Supplement to U.S. Food & Drug Administration to Expand Full-Body MRI Labeling for 3T Scans 9.7%
3/18 Form 4 Axonics Modulation Techn For: Mar 16 Filed by: COHEN RAYMOND W 8.8%
4/6 Form 4 Axonics Modulation Techn For: Apr 02 Filed by: Sama Rinda 8.3%
11/14 Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications 8.2%
4/14 Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator 7.1%
6/13 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its price target raised by analysts at Bank of America Corp from $30.00 to $35.00. They now have a "buy" rating on the stock. 6.8%
5/8 Q1/2019 3/31/2019 EPS -0.470 ZacksConsensus -0.400 ActVsEst (0.070) - Miss 19.5%
4/16 Form 8-K Axonics Modulation Techn For: Apr 16 13.3%
8/6 Form 4 Axonics Modulation Techn For: Aug 06 Filed by: COHEN RAYMOND W 10.3%
4/6 Axonics® Submits PMA Supplement to U.S. Food & Drug Administration to Expand Full-Body MRI Labeling for 3T Scans 9.7%
3/18 Form 4 Axonics Modulation Techn For: Mar 16 Filed by: COHEN RAYMOND W 8.8%
4/6 Form 4 Axonics Modulation Techn For: Apr 02 Filed by: Sama Rinda 8.3%
11/14 Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications 8.2%
4/14 Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator 7.1%
6/13 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its price target raised by analysts at Bank of America Corp from $30.00 to $35.00. They now have a "buy" rating on the stock. 6.8%
TOP News Decliners
3/16
Axonics® Announces Filing of Petitions Before the United States Patent and Trademark Office Contesting the Validity of Medtronic Patents
-21.0%
11/17 Axonics Modulation Technlogs INC (AXNX) Q3 2019 Earnings Call Transcript [The Motley Fool] -12.4%
3/9 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $48.00 price target on the stock. -10.0%
8/5 Axonics® Announces Second Quarter 2019 Financial Results and Operational Update -8.7%
3/4 Form 8-K Axonics Modulation Techn For: Mar 04 -8.0%
10/7 Axonics® Broadens EU Commercial Footprint with Recommendation for Reimbursement in France and Supply Contract in Norway -7.9%
9/9 Form 8-K Axonics Modulation Techn For: Sep 09 -7.8%
11/6 Form S-3 Axonics Modulation Techn -7.8%
11/14 Form 10-Q Axonics Modulation Techn For: Sep 30 -7.8%
4/21 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its price target lowered by analysts at Piper Sandler from $48.00 to $44.00. They now have an "overweight" rating on the stock. -7.2%
11/17 Axonics Modulation Technlogs INC (AXNX) Q3 2019 Earnings Call Transcript [The Motley Fool] -12.4%
3/9 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $48.00 price target on the stock. -10.0%
8/5 Axonics® Announces Second Quarter 2019 Financial Results and Operational Update -8.7%
3/4 Form 8-K Axonics Modulation Techn For: Mar 04 -8.0%
10/7 Axonics® Broadens EU Commercial Footprint with Recommendation for Reimbursement in France and Supply Contract in Norway -7.9%
9/9 Form 8-K Axonics Modulation Techn For: Sep 09 -7.8%
11/6 Form S-3 Axonics Modulation Techn -7.8%
11/14 Form 10-Q Axonics Modulation Techn For: Sep 30 -7.8%
4/21 Axonics Modulation Technologies Inc (NASDAQ: AXNX) had its price target lowered by analysts at Piper Sandler from $48.00 to $44.00. They now have an "overweight" rating on the stock. -7.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: